FDA cleared the MIM LesionID Pro from Mim Software, Inc. on Dec 11, 2025 under K251883, a traditional 510(k). The device falls under product code LLZ, System, Image Processing, Radiological, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Jun 20, 2025. The decision came 174 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
Mim Software, Inc. has one other decision in the tracker over the last 12 months: K253270 (Contour ProtégéAI+).